Journal of Cardiovascular Electrophysiology

570 posts

Journal of Cardiovascular Electrophysiology banner
Journal of Cardiovascular Electrophysiology

Journal of Cardiovascular Electrophysiology

@JCardioEP

Dedicated to providing the highest quality and most clinically relevant content, showcasing the changing and interconnected world of global electrophysiology.

Katılım Eylül 2018
262 Takip Edilen7.2K Takipçiler
Journal of Cardiovascular Electrophysiology retweetledi
Hawkins Gay, MD, MPH
Hawkins Gay, MD, MPH@hcg_md·
PWI is definitely not appropriate for all patients with persistent AF. It has been shown to be effective in some cases (low/fractionated voltage, high burden of spatiotemporal dispersion) but in select trials without replication. Persistent AF is an area ripe for continued investigation w/ #AI and advanced signal/vector analysis. We will almost certainly find that a ‘tailored’ / individualized approach is better than one size fits all. @VoltaMedical @VektorMedical
Roderick Tung@DrRoderickTung

PVI+ is the one area where RCTs have been unable to supercede anecdotes – because operator bias is so powerful. Only two randomized trials have shown efficacy beyond PVI (CONVERGE and VENUS), yet only a minority have adopted. And multiple PWI studies show no systematic benefit when applied widely, yet the majority continue to do so in persistent patients. The time is ripe for personalization targeting individual mechanisms, as one size has been proven to not fit all.

English
0
3
22
5.7K
Journal of Cardiovascular Electrophysiology retweetledi
Roderick Tung
Roderick Tung@DrRoderickTung·
PVI+ is the one area where RCTs have been unable to supercede anecdotes – because operator bias is so powerful. Only two randomized trials have shown efficacy beyond PVI (CONVERGE and VENUS), yet only a minority have adopted. And multiple PWI studies show no systematic benefit when applied widely, yet the majority continue to do so in persistent patients. The time is ripe for personalization targeting individual mechanisms, as one size has been proven to not fit all.
peterkistler MBBS PhD FHRS@peterkistler3

What’s the obsession with PWI in AF ablation? It may appear “safe & easy” ⁦@drjohnm⁩ BUT no randomised evidence & there is downside #TWIC Oct 10

English
8
31
122
24.1K
Journal of Cardiovascular Electrophysiology
A 72 y.o. man with a CRT-D developed acute HF due to biventricular pacing tachycardia > 100/min. Frequent ventricular ectopics activated ventricular rate stabilisation for rate smoothing which paradoxically worsened heart failure. #Epeeps
English
0
0
0
455
Journal of Cardiovascular Electrophysiology
With cannabis use on the rise, what are the cardiac risks? This large multicenter study reveals cannabis users face higher rates of atrial & ventricular arrhythmias compared to matched controls. #Epeeps
English
0
0
1
405
Journal of Cardiovascular Electrophysiology
VT Ablation in #LVAD Patients  (325 ablations, 300 patients): -  VT recurrence: 38% - Complication rate: 8% - Most common mechanism: Scar-related VT - Novel finding: HM3-specific EMI in ~50% of cases #EPeeps
English
0
0
1
360
Journal of Cardiovascular Electrophysiology
New insights in hybrid AF ablation: functional gaps & atrial fibrosis predict early arrhythmia recurrence. High-density mapping helps target completion lesions and improve rhythm success. #Epeeps
English
0
1
1
324
Journal of Cardiovascular Electrophysiology
V6 R-wave peak time during right ventricular septal pacing predicts successful LBBAP implantation in heart failure patients with LBBB. This simple ECG marker correlates with scar burden and guides intra-operative CRT strategy. #LBBAP #CRT #EPeeps
English
0
0
1
437
Journal of Cardiovascular Electrophysiology
Findings from this single-center analysis show that PFA is beneficial in AF patients regardless of their age by being associated with either significantly higher arrhythmia-free survival or longer time to recurrence compared to similar age-group patients undergoing thermal CA
English
0
0
0
338
Journal of Cardiovascular Electrophysiology
✅In Cyprus, sudden death affects 1 in 46,000 people aged 1–35 years annually, mostly due to cardiomyopathies. >25% occur during sports. This 11-year national epidemiological study provides key data on sudden deaths, highlighting the need for early screening and genetic testing.
English
0
0
1
438